ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
128.531,71
-0,02%
S&P 500
6.129,58
0,24%
US Dollar vs BRL
5,6899
0,00%
Bitcoin
95.509,90
-0,06%
Brent Oil
75,625
0,18%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. GT Biopharma Inc (GTBP)

  7. GT Biopharma Inc (GTBP) Notícias

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GTBP
DataHoraFonteTítuloCódigoCompanhia
07/02/202511:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
27/01/202509:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
23/12/202419:23Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GTBPGT Biopharma Inc
14/11/202418:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
21/10/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
17/10/202412:15Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GTBPGT Biopharma Inc
17/06/202417:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
13/06/202417:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
23/05/202421:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
23/05/202407:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
06/11/202319:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
27/10/202318:23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
19/09/202312:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
05/05/202318:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202318:29Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GTBPGT Biopharma Inc
04/05/202320:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTBPGT Biopharma Inc
04/05/202310:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
11/04/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTBPGT Biopharma Inc
30/03/202318:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GTBPGT Biopharma Inc
14/02/202314:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GTBPGT Biopharma Inc
04/01/202308:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GTBPGT Biopharma Inc
21/10/202207:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GTBPGT Biopharma Inc
13/09/202207:20TipRanksAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX), Ascendis Pharma (ASND) and GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
17/08/202218:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GTBPGT Biopharma Inc
15/08/202210:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTBPGT Biopharma Inc
25/07/202217:36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GTBPGT Biopharma Inc
19/05/202212:45TipRanksB.Riley Financial Thinks GT Biopharma’s Stock is Going to RecoverNASDAQ:GTBPGT Biopharma Inc
29/04/202218:21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GTBPGT Biopharma Inc
19/04/202218:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GTBPGT Biopharma Inc
12/04/202207:26TipRanksGT Biopharma (GTBP) Receives a Buy from H.C. WainwrightNASDAQ:GTBPGT Biopharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GTBP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
BRKM5
BRASKEM PNA
BOV
AZEV4
AZEVEDO PN
BOV
AZTE3
Azevedo & Travassos Ener... ON
BOV
AZEV3
AZEVEDO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios